Symbiosis Capital Partners, Llc

Institutional manager — quarterly 13F holdings, Q ending 2026-03-31

Reported value

$52.8M

Q ending 2026-03-31

Prior quarter

$109.5M

Q ending 2025-12-31

Change

-51.8% QoQ

Positions

reported holdings

Largest positions

All 6 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.

Holding	Ticker	Type	Value ▼	Shares
Evommune, Inc.	EVMN	Shares	$29.4M	1.3M
Inventiva S.A.	IVA	Shares	$13.1M	2.4M
Wave Life Sciences Ltd.		Shares	$5.4M	750K
Rani Therapeutics Holdings, Inc.	RANI	Shares	$2.7M	3.7M
Clene Nanomedicine Inc.	CLNN	Shares	$2.1M	431K
Surrozen, Inc.	SRZNW	Shares	$2K	150K

Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.